Trastuzumab

In the US, Trastuzumab (trastuzumab systemic) is a member of the drug class HER2 inhibitors and is used to treat Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer - Metastatic, Esophageal Carcinoma, Gastric Cancer and Salivary Gland Cancer.

US matches:

• Trastuzumab


• Trastuzumab Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XC03

CAS registry number (Chemical Abstracts Service)

0180288-69-1

Chemical Formula

C6470-H10012-N1726-O2013-S42

Molecular Weight

145532

Therapeutic Categories

Biological response modifier, BRM

Immunomodulator

Chemical Name

Immunoglobulin G1 (human-mouse monoclonal rhuMab HER2-gamma1-chain antihuman p185c-erbB2receptor), disulfide with human-mouse monoclonal rhuMab HER2 light chain, dimer (WHO)

Foreign Names

• Trastuzumabum (Latin)
• Trastuzumab (German)
• Trastuzumab (French)
• Trastuzumab (Spanish)

Generic Names

• Trastuzumab (OS: BAN, USAN, DCF)
• Anti-HER-2 monoclonal antibody (IS)
• MAB anti-HER-2 (IS)

Brand Names

• Herceptin
  Chugai, Japan; Genentech, United States; Roche, United Arab Emirates; Roche, Argentina; Roche, Austria; Roche, Australia; Roche, Bosnia & Herzegowina; Roche, Bangladesh; Roche, Belgium; Roche, Bahrain; Roche, Benin; Roche, Bolivia; Roche, Brazil; Roche, Canada; Roche, Switzerland; Roche, Chile; Roche, China; Roche, Colombia; Roche, Costa Rica; Roche, Cuba; Roche, Cyprus; Roche, Czech Republic; Roche, Germany; Roche, Denmark; Roche, Ecuador; Roche, Estonia; Roche, Egypt; Roche, Finland; Roche, France; Roche, United Kingdom; Roche, Georgia; Roche, Greece; Roche, Hong Kong; Roche, Croatia (Hrvatska); Roche, Hungary; Roche, Indonesia; Roche, Ireland; Roche, Israel; Roche, India; Roche, Iraq; Roche, Iran; Roche, Iceland; Roche, Italy; Roche, Jamaica; Roche, Jordan; Roche, Kuwait; Roche, Kazakhstan; Roche, Lebanon; Roche, Sri Lanka; Roche, Lithuania; Roche, Luxembourg; Roche, Morocco; Roche, Moldova; Roche, Mexico; Roche, Malaysia; Roche, Netherlands; Roche, Norway; Roche, New Zealand; Roche, Oman; Roche, Philippines; Roche, Pakistan; Roche, Poland; Roche, Portugal; Roche, Paraguay; Roche, Qatar; Roche, Romania; Roche, Serbia; Roche, Russian Federation; Roche, Saudi Arabia; Roche, Sweden; Roche, Slovenia; Roche, Slovakia; Roche, Syria; Roche, Thailand; Roche, Tunisia; Roche, Turkey; Roche, Trinidad & Tobago; Roche, Taiwan; Roche, Uruguay; Roche, Uzbekistan; Roche, Venezuela; Roche, Yemen; Roche, South Africa; Roche Diagnostic, Algeria; Roche RX, Singapore

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.